SANGSTAT MEDICAL CORP

Research SANGSTAT MEDICAL CORP (SANG) on Bullrun: market cap USD 130.79M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 130.79M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 219.70M-USD 5.55MUSD 24.42M70.6%-0.32USD 17.11MUSD 45.21MUSD 250.04M
FY2024USD 241.24M-USD 6.77MUSD 41.13M69.0%-0.42USD 17.07MUSD 70.32MUSD 257.31M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 130.79Mn/an/an/a
20252025-12-31USD 168.32Mn/an/an/a
20242024-12-31USD 239.85Mn/an/an/a
20232023-12-29USD 106.19Mn/an/an/a
20222022-12-30USD 107.20Mn/an/an/a
20212021-12-31USD 321.37Mn/an/an/a

About SANGSTAT MEDICAL CORP

Sangoma Technologies Corporation, together with its subsidiaries, develops, manufactures, distributes, and supports voice and data connectivity components for software-based communication applications in the United States of America and internationally. The company offers communications platforms comprising pure cloud and hybrid unified communications as a service, and on-premises systems; retail and wholesale SIP trunking, as well as fax as a service;

Related stock research

Other Technology stocks

Frequently asked questions

What is SANGSTAT MEDICAL CORP's market cap?

SANGSTAT MEDICAL CORP's market capitalization is USD 130.79M.

What does SANGSTAT MEDICAL CORP do?

Sangoma Technologies Corporation, together with its subsidiaries, develops, manufactures, distributes, and supports voice and data connectivity components for software-based communication applications in the United States of America and internationally.